Exelixis
EXEL
#1668
Rank
โ‚ฌ10.55 B
Marketcap
39,21ย โ‚ฌ
Share price
4.27%
Change (1 day)
22.17%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company